Active Ingredient History

  • Now
Dasotraline is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that was under development by Sunovion for the treatment of attention-deficit hyperactivity disorder (ADHD) and binge eating disorder (BED). Structurally, dasotraline is a stereoisomer of desmethylsertraline (DMS), which is an active metabolite of the marketed selective serotonin reuptake inhibitor (SSRI) antidepressant sertraline (Zoloft).   Wikipedia

  • SMILES: N[C@@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13
  • Mol. Mass: 292.21
  • ALogP: 4.92
  • ChEMBL Molecule:
More Chemistry
4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine | dasotraline | sep225289 | sep 225289 | sep-225289


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue